• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    MHRA Approves Flortaucipir For Cognitive Impairment In Alzheimer’s

    PHARMABIZ

    Avid Radiopharm`s Tauvid (flortaucipir (18F)) Receives Approval in Europe

    EMA

    FDA approves Lilly`s dye for mapping Alzheimer`s tau tangles

    FIERCE BIOTECH

    Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection)

    PRNEWSWIRE

    China approves first "Made in China" cancer drug

    BIOSPECTRUM

    Eli Lilly announces +ve results from ph 3 study of Flortaucipir F 18

    PHARMABIZ

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.